Zebrafish xenografts for drug discovery and personalized medicine J Xiao, E Glasgow, S Agarwal Trends in cancer 6 (7), 569-579, 2020 | 74 | 2020 |
Circulating tumor cells: technologies and their clinical potential in cancer metastasis J Xiao, PR Pohlmann, C Isaacs, BA Weinberg, AR He, R Schlegel, ... Biomedicines 9 (9), 1111, 2021 | 36 | 2021 |
Association of intraoperative cerebral and muscular tissue oxygen saturation with postoperative complications and length of hospital stay after major spine surgery: an … L Meng, J Xiao, K Gudelunas, Z Yu, Z Zhong, X Hu BJA: British Journal of Anaesthesia 118 (4), 551-562, 2017 | 36 | 2017 |
Efficient propagation of circulating tumor cells: a first step for probing tumor metastasis J Xiao, JR McGill, K Stanton, JD Kassner, S Choudhury, R Schlegel, ... Cancers 12 (10), 2784, 2020 | 16 | 2020 |
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer A Taber, Y Park, A Lelo, F Prip, J Xiao, DL Berry, K Chaldekas, JB Jensen, ... Urologic Oncology: Seminars and Original Investigations 39 (7), 438. e1-438. e9, 2021 | 13 | 2021 |
Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231 J Xiao, JR McGill, A Nasir, A Lekan, B Johnson, DJ Wilkins, GW Pearson, ... Molecular biomedicine 3 (1), 16, 2022 | 8 | 2022 |
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis J Xiao, U Sharma, A Arab, S Miglani, S Bhalla, S Suguru, R Suter, ... Cancers 15 (6), 1831, 2023 | 7 | 2023 |
Success rates and clinicopathologic associations with experimental outcomes of a novel circulating tumor cell (CTC) technology in advanced colon cancer (CC) and pancreatic … R Mukherji, S Suguru, J Xiao, X Geng, H Wang, MS Noel, AR He, ... Journal of Clinical Oncology 41 (4_suppl), 805-805, 2023 | 2 | 2023 |
Zebrafish xenografts to isolate unique human breast cancer metastatic cell populations J Xiao, JR McGill, A Nasir, A Lekan, B Johnson, DJ Wilkins, GW Pearson, ... bioRxiv, 2021.12. 07.471608, 2021 | 2 | 2021 |
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer L Gallagher, J Xiao, J Hsueh, S Shah, M Danner, A Zwart, M Ayoob, ... Frontiers in Oncology 13, 2023 | 1 | 2023 |
Propagated circulating tumor cells uncovers the role of NFκB and COP1 in metastasis J Xiao, U Sharma, A Arab, S Miglani, S Bhalla, S Suguru, R Suter, ... bioRxiv, 2022.12. 09.519805, 2022 | 1 | 2022 |
Patient adherence and early biochemical outcomes following relugolix with stereotactic body radiation therapy (SBRT) for unfavorable prostate cancer. L Gallagher, J Xiao, J Hsueh, S Shah, M Danner, A Zwart, M Ayoob, ... JCO Oncology Practice 19 (11_suppl), 526-526, 2023 | | 2023 |
State of the Art in the Propagation of Circulating Tumor Cells J Xiao, PR Pohlmann, R Schlegel, S Agarwal Circulating Tumor Cells: Advances in Liquid Biopsy Technologies, 247-274, 2023 | | 2023 |
Propagated Circulating Tumor Cells Uncover the Potential Role of NFκB, EMT, and TGFβ Signaling Pathways and COP1 in Metastasis. Cancers 2023, 15, 1831 J Xiao, U Sharma, A Arab, S Miglani, S Bhalla, S Suguru, R Suter, ... | | 2023 |
Establishing circulating tumor cell-derived xenografts following a period of in vitro culture J Xiao, R Schlegel, S Agarwal Cancer Research 82 (12_Supplement), 5123-5123, 2022 | | 2022 |
Investigating the Mechanisms of Cancer Metastasis Through Novel in Vitro and in Vivo Models J Xiao Georgetown University, 2022 | | 2022 |
A robust method for expanding patient-derived circulating tumor cells ex vivo J Xiao, JD Kassner, K Stanton, R Schlegel, PR Pohlmann, S Agarwal Cancer Research 81 (13_Supplement), 585-585, 2021 | | 2021 |
A scalable, non-biased screen for isolating functionally metastatic cell populations J Xiao, A Lekan, K Stanton, E Glasgow, S Agarwal Cancer Research 80 (16_Supplement), 6129-6129, 2020 | | 2020 |
Association of Cerebral and Muscular Tissue Oxygen Saturation With Perioperative Outcomes in Major Spine Surgery L Meng, J Xiao, K Gudelunas, Z Yu, SE Gruenbaum, PE Bickler, X Hu | | |